Celestial Biolabs Limited reported unaudited earnings results for the third quarter and nine months ended December 31, 2017. For the quarter, the company reported revenue from operations of INR 171.777 million, profit before exceptional and extraordinary items and tax of INR 6.534 million, profit before tax of INR 6.534 million and net profit of INR 6.534 million or INR 0.29 per diluted share compared to revenue from operations of INR 76.683 million, profit before exceptional and extraordinary items and tax of INR 8.664 million, profit before tax of INR 8.664 million and net profit of INR 7.013 million or INR 0.31 per diluted share reported in the same period last year. For the nine months, the company reported revenue from operations of INR 264.572 million, profit before exceptional and extraordinary items and tax of INR 20.425 million, profit before tax of INR 20.425 million and net profit of INR 17.856 million or INR 0.79 per diluted share compared to revenue from operations of INR 256.959 million, profit before exceptional and extraordinary items and tax of INR 21.897 million, profit before tax of INR 21.897 million and net profit of INR 17.725 million or INR 0.78 per diluted share reported in the same period last year.